Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period Of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-in Capital
Subscriptions Receivable
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period Of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2018     3,793,000 (122,000)          
Beginning balance at Dec. 31, 2018 $ (226,335)   $ 10 $ (30,659) $ 814,488 $ (597) $ (1,009,458)   $ (119)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Restricted stock units vested and distributed, net of tax (in shares)     13,000            
Restricted stock units vested and distributed, net of tax (117)       (117)        
Stock-based compensation 2,389       2,389        
Net income (loss) (37,609)       0   (37,609)    
Tax effect relating to the beneficial conversion feature of Second Lien Notes (2,688)       (2,688)   0    
Unrealized foreign currency translation adjustments 233               233
Ending balance (in shares) at Mar. 31, 2019     3,806,000 (122,000)          
Ending balance at Mar. 31, 2019 (264,127)   $ 10 $ (30,659) 814,072 (597) (1,047,067)   114
Beginning balance (in shares) at Dec. 31, 2018     3,793,000 (122,000)          
Beginning balance at Dec. 31, 2018 (226,335)   $ 10 $ (30,659) 814,488 (597) (1,009,458)   (119)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (76,069)                
Unrealized foreign currency translation adjustments 243                
Ending balance (in shares) at Jun. 30, 2019     3,827,000 (122,000)          
Ending balance at Jun. 30, 2019 (300,530)   $ 10 $ (30,659) 816,119 (597) (1,085,527)   124
Beginning balance (in shares) at Dec. 31, 2018     3,793,000 (122,000)          
Beginning balance at Dec. 31, 2018 $ (226,335)   $ 10 $ (30,659) 814,488 (597) (1,009,458)   (119)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201602Member                
Ending balance (in shares) at Dec. 31, 2019 3,715,775   3,838,000 (122,000)          
Ending balance at Dec. 31, 2019 $ (375,154) $ (1,287) $ 10 $ (30,659) 818,961 (597) (1,162,901) $ (1,287) 32
Beginning balance (in shares) at Mar. 31, 2019     3,806,000 (122,000)          
Beginning balance at Mar. 31, 2019 (264,127)   $ 10 $ (30,659) 814,072 (597) (1,047,067)   114
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Restricted stock units vested and distributed, net of tax (in shares)     21,000            
Restricted stock units vested and distributed, net of tax (147)       (147)        
Stock-based compensation 2,194       2,194        
Net income (loss) (38,460)           (38,460)    
Unrealized foreign currency translation adjustments 10               10
Ending balance (in shares) at Jun. 30, 2019     3,827,000 (122,000)          
Ending balance at Jun. 30, 2019 $ (300,530)   $ 10 $ (30,659) 816,119 (597) (1,085,527)   124
Beginning balance (in shares) at Dec. 31, 2019 3,715,775   3,838,000 (122,000)          
Beginning balance at Dec. 31, 2019 $ (375,154) (1,287) $ 10 $ (30,659) 818,961 (597) (1,162,901) (1,287) 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Restricted stock units vested and distributed, net of tax (in shares)     29,000            
Restricted stock units vested and distributed, net of tax (61)       (61)        
Stock-based compensation 1,339       1,339        
Net income (loss) (80,925)           (80,925)    
Unrealized foreign currency translation adjustments 237               237
Ending balance (in shares) at Mar. 31, 2020     3,867,000 (122,000)          
Ending balance at Mar. 31, 2020 $ (455,851) 0 $ 10 $ (30,659) 820,239 (597) (1,245,113) 0 269
Beginning balance (in shares) at Dec. 31, 2019 3,715,775   3,838,000 (122,000)          
Beginning balance at Dec. 31, 2019 $ (375,154) (1,287) $ 10 $ (30,659) 818,961 (597) (1,162,901) (1,287) 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (138,958)                
Unrealized foreign currency translation adjustments $ 278                
Ending balance (in shares) at Jun. 30, 2020 3,754,656   3,877,000 (122,000)          
Ending balance at Jun. 30, 2020 $ (512,858)   $ 10 $ (30,659) 821,224 (597) (1,303,146)   310
Beginning balance (in shares) at Mar. 31, 2020     3,867,000 (122,000)          
Beginning balance at Mar. 31, 2020 (455,851) $ 0 $ 10 $ (30,659) 820,239 (597) (1,245,113) $ 0 269
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Restricted stock units vested and distributed, net of tax (in shares)     10,000            
Restricted stock units vested and distributed, net of tax (67)       (67)        
Stock-based compensation 1,052       1,052        
Net income (loss) (58,033)           (58,033)    
Unrealized foreign currency translation adjustments $ 41               41
Ending balance (in shares) at Jun. 30, 2020 3,754,656   3,877,000 (122,000)          
Ending balance at Jun. 30, 2020 $ (512,858)   $ 10 $ (30,659) $ 821,224 $ (597) $ (1,303,146)   $ 310